[The results of hypofractionated irradiation in patients with bronchogenic carcinoma].
Resulting from the declared palliative aim and from time economic and tumor affecting high dosed single fraction meanwhile a hypofractionated irradiation rhythm was applied to more than 500 patients with lung carcinoma and 5 x 5 Gy were given in daily succession if possible. A hospitalization was necessary in a third of the patients. In spite of histology (NSCLC: 46%, SCLC: 35%) a mean survival of 12 months was attained, in which the fate is determined for 75% of the patients within the first year after therapy. Detrimental effects were not provoked by the applied irradiation mode.
Lesche
A
A
Strahlentherapieabteilung, Medizinische Akademie Carl Gustav Carus, Dresden.
Kulpe
T
T
D002283:Carcinoma, Bronchogenic / Q000532:radiotherapy*; D002289:Carcinoma, Non-Small-Cell Lung / Q000532:radiotherapy*; D018288:Carcinoma, Small Cell / Q000532:radiotherapy*; D006801:Humans; D008175:Lung Neoplasms / Q000532:radiotherapy*; D010166:Palliative Care; D011879:Radiotherapy Dosage
Ergebnisse hypofraktionierter Bestrahlung bei Patienten mit Bronchialkarzinom.